NCT06377527

Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 2,000 (estimated)
• Sponsor: M.D. Anderson Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.

Detailed description

Primary Objectives 1\. To collect data on participants characteristics, disease characterization, pathology and molecular data, treatment, and outcomes for participants with gynecologic mesonephric-like adenocarcinoma (MLA). Secondary Objectives 1. To organize clinical information to support multifaceted queries of participant characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with participant outcome. 2. To have a single data repository kept on a secure platform that will integrate clinical information and research findings and serve as an archive for future research.

Conditions

• Mesonephric-like Adenocarcinoma

Timeline

• Start date: 2024-07-10
• Primary completion: 2035-12-28
• Completion: 2037-12-28
• First posted: 2024-04-22
• Last updated: 2025-12-26

Locations

1 site across 1 country: United States